Diversity

Expert Meetings

Overview

The underrepresentation of diverse populations in clinical trials creates knowledge gaps about the risks and benefits of drugs and devices for the public. To address this discrepancy, CTTI is working to determine the value of including diverse patient populations throughout the entire medical product development lifecycle — from early target identification all the way to data lock and submission.  

These recommendations and resources will help stakeholders adopt new organization-level practices that increase diversity in clinical trials, leading to enriched research results that are more relevant for everyone. 

Solutions

Search All

News

Case Study

    In Detail